Opinion ID: 4511614
Heading Depth: 4
Heading Rank: 1

Heading: pharmacy benefits management (PBM)

Text: . . .; (ii) retail, which includes the sale of prescription drugs, over-the-counter medications, [and other products and services sold by CVS's retail pharmacies] (Retail); (iii) retail health clinics (MinuteClinic); (iv) the provision of [various products and services] to long-term care facilities, other healthcare service providers and recipients of services from such facilities (Long-Term Care); (v) the provision of prescription infusion drugs and related services (Infusion); and (vi) any other business in which [the] Corporation is engaged or imminently will be engaged. . . . . The Parties acknowledge that . . . an entity will be considered a Competitor if it provides products or services competitive with the products and services provided by the Corporation within the last two years of my employment. I agree to this enterprise-wide definition of non-competition which may prevent me from providing services to any of the Corporation's PBM, Retail, MinuteClinic, Long-Term Care and Infusion Competitors or any combination thereof . . . . This definition of Competition and the eighteen-month noncompetition period appear in all four of the RCAs that Lavin signed. However, the definition of Competitor expanded over time. The 2011 and 2012 RCAs limited Competitors to other companies providing PBM services. The 2014 RCA expanded this definition to include retail pharmacies and health clinics, as well as any other entity that provides products or services competitive with the products and services provided by the - 6 - Corporation within the last two years of Lavin's employment. By 2017, as stated above, the definition of Competitor included companies providing services to long-term care facilities and prescription infusion drugs.